Published in J Innate Immun on August 28, 2008
Toll-like receptor signaling pathways--therapeutic opportunities. Mediators Inflamm (2010) 1.58
Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue. Br J Cancer (2013) 1.06
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma. J Exp Clin Cancer Res (2011) 0.98
Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL10 production in males. PLoS One (2012) 0.96
TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients. BMC Cancer (2010) 0.93
Toll-like receptor 9 in breast cancer. Front Immunol (2014) 0.89
DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells. Breast Cancer Res Treat (2013) 0.87
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer. Oncol Lett (2013) 0.86
IL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy Resistance. Front Immunol (2014) 0.86
Tumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma. Oncoimmunology (2015) 0.81
Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro. Oncol Lett (2014) 0.79
Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo. Oncotarget (2016) 0.75
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans. PLoS One (2017) 0.75
Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer (2002) 2.82
Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J Biol Chem (2002) 1.95
A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol (2007) 1.93
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res (2006) 1.69
Influence of distribution of lean body mass on resting metabolic rate after weight loss and weight regain: comparison of responses in white and black women. Am J Clin Nutr (2003) 1.67
Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. Sex Transm Dis (2005) 1.56
Impact of staging transesophageal EUS on treatment and survival in patients with non-small-cell lung cancer. Gastrointest Endosc (2008) 1.50
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate (2007) 1.37
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Ann Thorac Surg (2005) 1.33
Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma. Laryngoscope (2003) 1.22
Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Res (2004) 1.20
Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion. Mol Cancer Res (2008) 1.18
An essential role for gp130 in neointima formation following arterial injury. Circ Res (2007) 1.15
Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases. Cancer Epidemiol Biomarkers Prev (2007) 1.12
Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy. Diabetes Care (2004) 1.09
Gender Differences in the Association between Sleep Duration and Body Composition: The Cardia Study. Int J Endocrinol (2009) 1.08
Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors. Prostate (2010) 1.08
Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss. Prostate (2009) 1.06
Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun (2011) 1.06
Effect of group vs. single housing on phenotypic variance in C57BL/6J mice. Obes Res (2002) 1.02
Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology (2011) 0.99
Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. Environ Health Perspect (2011) 0.98
Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells. Breast Cancer Res Treat (2011) 0.98
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer. Breast Cancer Res Treat (2012) 0.98
Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion. APMIS (2012) 0.98
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice. Clin Exp Metastasis (2004) 0.98
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma. J Exp Clin Cancer Res (2011) 0.98
Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg (2003) 0.97
Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia. Virchows Arch (2013) 0.96
Behavioral transitions and weight change patterns within the PREMIER trial. Obesity (Silver Spring) (2011) 0.96
Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer. Am J Gastroenterol (2003) 0.95
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer. Int J Cancer (2004) 0.93
Distinct classes of c-Kit-activating mutations differ in their ability to promote RUNX1-ETO-associated acute myeloid leukemia. Blood (2011) 0.93
Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo. Clin Cancer Res (2006) 0.92
Sexually transmitted disease/HIV transmission risk behaviors and sexually transmitted disease prevalence among HIV-positive men receiving continuing care. Sex Transm Dis (2005) 0.90
Prevalence and factors associated with gonorrhea and chlamydial infection in at-risk females presenting to an urban emergency department. Sex Transm Dis (2003) 0.90
Unmet need for medical care and safety net accessibility among Birmingham's homeless. J Urban Health (2014) 0.89
Is socioeconomic status of the rearing environment causally related to obesity in the offspring? PLoS One (2011) 0.88
DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells. Breast Cancer Res Treat (2013) 0.87
Validation of ultrasonography to evaluate murine orthotopic oral cavity tumors. ORL J Otorhinolaryngol Relat Spec (2006) 0.87
Population-based study of the geographic variation in colon cancer incidence in Alabama: relationship to socioeconomic status indicators and physician density. South Med J (2005) 0.87
Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells. Eur J Pharmacol (2007) 0.87
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer. Oncol Lett (2013) 0.86
Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice. Clin Exp Metastasis (2009) 0.86
Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use. Obesity (Silver Spring) (2006) 0.86
Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease. Dement Geriatr Cogn Disord (2008) 0.84
The role of ultrasonography in parathyroid surgery. Arch Otolaryngol Head Neck Surg (2007) 0.84
Assessment of erlotinib as adjuvant chemoprevention in high-risk head and neck cancer patients. Ann Surg Oncol (2014) 0.83
Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery. J Am Acad Dermatol (2004) 0.83
Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition. Breast Cancer Res Treat (2003) 0.83
Relationship between metabolic function and skeletal muscle fatigue during a 90 s maximal isometric contraction. Appl Physiol Nutr Metab (2007) 0.82
The safety of flavocoxid, a medical food, in the dietary management of knee osteoarthritis. J Med Food (2009) 0.82
Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis. Int J Oncol (2013) 0.82
Natural history of asymptomatic bacterial vaginosis in a high-risk group of women. Sex Transm Dis (2007) 0.81
Variable selection in logistic regression for detecting SNP-SNP interactions: the rheumatoid arthritis example. Eur J Hum Genet (2008) 0.81
Tumor necrosis factor-alpha induces interleukin-6 production via extracellular-regulated kinase 1 activation in breast cancer cells. Breast Cancer Res Treat (2003) 0.81
Fruit and vegetable pricing by demographic factors in the Birmingham, Alabama, metropolitan area, 2004-2005. Prev Chronic Dis (2010) 0.81
A bipartite interaction between Pseudomonas aeruginosa and fungi in onychomycosis. Arch Dermatol (2005) 0.80
Health-seeking behaviors and sexually transmitted diseases among adolescents attending an urban pediatric emergency department. Compr Ther (2007) 0.79
Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer. Oncol Lett (2013) 0.78
Parametric modeling of localized melanoma prognosis and outcome. J Biopharm Stat (2009) 0.78
Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2012) 0.78
Hardware removal after osseous free flap reconstruction. Otolaryngol Head Neck Surg (2013) 0.78
Diet variety based on macronutrient intake and its relationship with body mass index. MedGenMed (2006) 0.77
Differential effects of Ca(2+) on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells. Eur J Pharmacol (2006) 0.77
C-reactive protein and glycemic control in adults with diabetes: response to King et al. Diabetes Care (2004) 0.75
Baseline inflammatory markers do not modulate the lipid response to weight loss. Metabolism (2008) 0.75
Pilot Trial of a Home-based Physical Activity Program for African American Women. Med Sci Sports Exerc (2017) 0.75
Characteristics of photopheresis treatments for the management of rejection in heart and lung transplant recipients. J Clin Apher (2002) 0.75
Nonprogression of vertebral area or bone mineral content on DXA does not predict compression fractures. J Clin Densitom (2006) 0.75
[Palliative (symptomatic) care of (imminently) dying patients]. Duodecim (2013) 0.75